Skip to main content
. 2016 Aug 18;6:31694. doi: 10.1038/srep31694

Figure 5. Cell migration is inhibited by cytochalasin D and mitomycin C.

Figure 5

(a) 14 hour migration assays of EPC2 (EPC), CP-A (CPA), HeLa, and Swiss 3T3 (3T3) cells that were exposed to 1 μg/mL cytochalasin D (cyto D) during migration, or pretreated for 2 hours with 10 μg/mL mitomycin C (MMC) immediately prior to migration. (b) Migration results pooled from three independent experiments as in (a). Cytochalasin D significantly inhibited migration in all cell types, while mitomycin C inhibited migration of EPC2 and CP-A cells but not HeLa or Swiss 3T3 cells. (c) A panel of human breast epithelial cell lines, HME1 (HME), MCF 10A, MCF7, and MDA-MB-231(MDA) were treated with cytochalasin D (cyto D), or mitomycin C (MMC). (d) Migration results pooled from three independent experiments as in (c). Under control conditions, MCF7 migration was significantly lower than both MCF 10A and MDA-MB-231. Cytochalasin D treatment inhibited migration in all cell lines except MCF7, and mitomycin C had no effect on any cell line. Data in (b,d) present the means of three independent experiments each performed in duplicate and error bars indicate SEM. * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001, **** indicates p < 0.0001. Data were analyzed by two-way ANOVA with Tukey’s multiple comparisons test.